Published in Spinal Cord on December 19, 2006
Autologous olfactory ensheathing cell transplantation in human paraplegia: a 3-year clinical trial. Brain (2008) 2.99
Stem cell therapy in spinal trauma: Does it have scientific validity? Indian J Orthop (2015) 2.08
Antioxidant therapies in traumatic brain and spinal cord injury. Biochim Biophys Acta (2011) 1.48
Respiratory neuroplasticity and cervical spinal cord injury: translational perspectives. Trends Neurosci (2008) 1.46
Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: clinical trial design. Spinal Cord (2006) 1.39
Stem cell therapies for spinal cord injury. Nat Rev Neurol (2010) 1.35
A systematic review of functional ambulation outcome measures in spinal cord injury. Spinal Cord (2007) 1.27
Outcome measures in spinal cord injury: recent assessments and recommendations for future directions. Spinal Cord (2009) 1.23
Recovery from chronic spinal cord contusion after Nogo receptor intervention. Ann Neurol (2011) 1.18
What should an ideal spinal injury classification system consist of? A methodological review and conceptual proposal for future classifications. Eur Spine J (2010) 1.07
Curiosity and cure: translational research strategies for neural repair-mediated rehabilitation. Dev Neurobiol (2007) 1.05
Cellular treatments for spinal cord injury: the time is right for clinical trials. Neurotherapeutics (2011) 1.01
Comparison of training methods to improve walking in persons with chronic spinal cord injury: a randomized clinical trial. J Spinal Cord Med (2011) 1.00
A systematic review of the effects of pharmacological agents on walking function in people with spinal cord injury. J Neurotrauma (2012) 0.98
Axon growth inhibition by RhoA/ROCK in the central nervous system. Front Neurosci (2014) 0.97
Clinical predictors of recovery after blunt spinal cord trauma: systematic review. J Neurotrauma (2010) 0.94
Development of a universal measure of quadrupedal forelimb-hindlimb coordination using digital motion capture and computerised analysis. BMC Neurosci (2007) 0.94
Common data elements for spinal cord injury clinical research: a National Institute for Neurological Disorders and Stroke project. Spinal Cord (2015) 0.91
Neurotrauma and mesenchymal stem cells treatment: From experimental studies to clinical trials. World J Stem Cells (2014) 0.90
Templated agarose scaffolds for the support of motor axon regeneration into sites of complete spinal cord transection. Biomaterials (2012) 0.89
Outcome Measures for Acute/Subacute Cervical Sensorimotor Complete (AIS-A) Spinal Cord Injury During a Phase 2 Clinical Trial. Top Spinal Cord Inj Rehabil (2012) 0.89
The influence of time from injury to surgery on motor recovery and length of hospital stay in acute traumatic spinal cord injury: an observational Canadian cohort study. J Neurotrauma (2014) 0.87
Minimizing errors in acute traumatic spinal cord injury trials by acknowledging the heterogeneity of spinal cord anatomy and injury severity: an observational Canadian cohort analysis. J Neurotrauma (2014) 0.87
Impact of multiple injuries on functional and neurological outcomes of patients with spinal cord injury. Scand J Trauma Resusc Emerg Med (2013) 0.87
Methods for functional assessment after C7 spinal cord hemisection in the rhesus monkey. Neurorehabil Neural Repair (2012) 0.86
Volitional muscle strength in the legs predicts changes in walking speed following locomotor training in people with chronic spinal cord injury. Phys Ther (2011) 0.85
Delayed Imatinib Treatment for Acute Spinal Cord Injury: Functional Recovery and Serum Biomarkers. J Neurotrauma (2015) 0.84
A systematic review of the efficacy of gait rehabilitation strategies for spinal cord injury. Top Spinal Cord Inj Rehabil (2007) 0.83
Motor levels in high cervical spinal cord injuries: Implications for the International Standards for Neurological Classification of Spinal Cord Injury. J Spinal Cord Med (2016) 0.82
Spinal cord injury: Visualizing plasticity and repair in the injured CNS. Nat Rev Neurol (2013) 0.82
Respiration following spinal cord injury: evidence for human neuroplasticity. Respir Physiol Neurobiol (2013) 0.82
Age, gender, and side differences of cutaneous electrical perceptual threshold testing in an able-bodied population. J Spinal Cord Med (2010) 0.81
Spinal cord injury: is monitoring from the injury site the future? Crit Care (2016) 0.81
Developing a spinal cord injury research strategy using a structured process of evidence review and stakeholder dialogue. Part II: Background to a research strategy. Spinal Cord (2015) 0.80
Longitudinal changes in body composition and metabolic profile between exercise clinical trials in men with chronic spinal cord injury. J Spinal Cord Med (2016) 0.80
Traversing the translational trail for trials. Top Spinal Cord Inj Rehabil (2012) 0.79
A Systematic Review of Experimental Strategies Aimed at Improving Motor Function after Acute and Chronic Spinal Cord Injury. J Neurotrauma (2016) 0.78
Effect of overground training augmented by mental practice on gait velocity in chronic, incomplete spinal cord injury. Arch Phys Med Rehabil (2013) 0.78
Clinical outcome of autologous mononuclear cells transplantation for spinal cord injury: a systematic review and meta-analysis. Med J Islam Repub Iran (2014) 0.78
Changes in electrical perceptual threshold in the first 6 months following spinal cord injury. J Spinal Cord Med (2011) 0.78
International standards for neurological classification of spinal cord injury: impact of the revised worksheet (revision 02/13) on classification performance. J Spinal Cord Med (2016) 0.77
Case Report: Combination Therapy with Mesenchymal Stem Cells and Granulocyte-Colony Stimulating Factor in a Case of Spinal Cord Injury. Basic Clin Neurosci (2015) 0.77
Using recombinant Rho protein antagonist in acute spinal cord injury; does this go further from conventional decompressions? Front Neurol (2013) 0.75
The corticomotor projection to liminally-contractable forearm muscles in chronic spinal cord injury: a transcranial magnetic stimulation study. Spinal Cord (2016) 0.75
Quality of residual neuromuscular control and functional deficits in patients with spinal cord injury. Front Neurol (2013) 0.75
Rituximab in the treatment of severe lupus myelopathy. Clin Rheumatol (2011) 0.75
Minimally manipulated autologous adherent bone marrow cells (ABMCs): a promising cell therapy of spinal cord injury. Neural Regen Res (2015) 0.75
Evaluation of the Walking Index for Spinal Cord Injury II (WISCI-II) in children with Spinal Cord Injury (SCI). Spinal Cord (2016) 0.75
Robot-aided assessment of lower extremity functions: a review. J Neuroeng Rehabil (2016) 0.75
An integrative review of standardized clinical evaluation tool utilization in anticholinergic drug trials for neurogenic lower urinary tract dysfunction. Spinal Cord (2016) 0.75
Spinal Cord Injury-Assessing Tolerability and Use of Combined Rehabilitation and NeuroAiD (SATURN Study): Protocol of An Exploratory Study In Assessing the Safety and Efficacy of NeuroAiD Amongst People Who Sustain Severe Spinal Cord Injury. JMIR Res Protoc (2016) 0.75
Discrepancies between clinical assessments of sensory function and electrical perceptual thresholds after incomplete chronic cervical spinal cord injury. Spinal Cord (2015) 0.75
Are you "tilting at windmills" or undertaking a valid clinical trial? Yonsei Med J (2011) 0.75
SCISSOR-Spinal Cord Injury Study on Small molecule-derived Rho inhibition: a clinical study protocol. BMJ Open (2016) 0.75
Tolerability and efficacy of erythropoietin (EPO) treatment in traumatic spinal cord injury: a preliminary randomized comparative trial vs. methylprednisolone (MP). Neurol Sci (2015) 0.75
A machine learning approach for specification of spinal cord injuries using fractional anisotropy values obtained from diffusion tensor images. Comput Math Methods Med (2014) 0.75
Autoregressive transitional ordinal model to test for treatment effect in neurological trials with complex endpoints. BMC Med Res Methodol (2016) 0.75
Clinical Trial of Human Fetal Brain-Derived Neural Stem/Progenitor Cell Transplantation in Patients with Traumatic Cervical Spinal Cord Injury. Neural Plast (2015) 0.75
Mechanical and Thermal Sensory Testing in Normal Chondrodystrophoid Dogs and Dogs with Spinal Cord Injury caused by Thoracolumbar Intervertebral Disc Herniations. J Vet Intern Med (2016) 0.75
Cervical spinal cord injury: tailoring clinical trial endpoints to reflect meaningful functional improvements. Neural Regen Res (2014) 0.75
Subject-specific regional measures of water diffusion are associated with impairment in chronic spinal cord injury. Neuroradiology (2017) 0.75
Recovery of supraspinal control of leg movement in a chronic complete flaccid paraplegic man after continuous low-frequency pelvic nerve stimulation and FES-assisted training. Spinal Cord Ser Cases (2017) 0.75
Spinal cord ability ruler: an interval scale to measure volitional performance after spinal cord injury. Spinal Cord (2017) 0.75
Food-related illness and death in the United States. Emerg Infect Dis (1999) 39.22
Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs. Nature (2002) 28.79
Antisense transcription in the mammalian transcriptome. Science (2005) 15.69
Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli. Antimicrob Agents Chemother (1990) 11.71
Nucleotide sequence of cloned cDNA for bovine corticotropin-beta-lipotropin precursor. Nature (1979) 6.56
Quinolone resistance-determining region in the DNA gyrase gyrB gene of Escherichia coli. Antimicrob Agents Chemother (1991) 6.19
International Standards for Neurological and Functional Classification of Spinal Cord Injury. American Spinal Injury Association. Spinal Cord (1997) 5.91
Reactive astrocytes: cellular and molecular cues to biological function. Trends Neurosci (1997) 4.92
Recovery of motor function after spinal-cord injury--a randomized, placebo-controlled trial with GM-1 ganglioside. N Engl J Med (1991) 4.56
Cloning of the gamma chain of the human IL-2 receptor. Science (1992) 4.50
Sharing of the interleukin-2 (IL-2) receptor gamma chain between receptors for IL-2 and IL-4. Science (1993) 4.39
Epidemiology, demographics, and pathophysiology of acute spinal cord injury. Spine (Phila Pa 1976) (2001) 4.09
Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms. J Neurosurg (1991) 3.85
Purification of a pluripotent neural stem cell from the adult mouse brain. Nature (2001) 3.78
gyrA and gyrB mutations in quinolone-resistant strains of Escherichia coli. Antimicrob Agents Chemother (1989) 3.67
Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis. Brain (2007) 3.64
Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: spontaneous recovery after spinal cord injury and statistical power needed for therapeutic clinical trials. Spinal Cord (2006) 3.55
Inducible expression of H-2 and Ia antigens on brain cells. Nature (1984) 3.48
On the process of cellular division in Escherichia coli: nucleotide sequence of the gene for penicillin-binding protein 3. Mol Gen Genet (1983) 3.43
Rifampicin resistance and mutation of the rpoB gene in Mycobacterium tuberculosis. FEMS Microbiol Lett (1996) 3.40
Pin1 regulates turnover and subcellular localization of beta-catenin by inhibiting its interaction with APC. Nat Cell Biol (2001) 3.26
Regressive events in neurogenesis. Science (1984) 3.24
Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2. J Exp Med (2001) 3.23
Light-dependent translocation of a phytochrome B-GFP fusion protein to the nucleus in transgenic Arabidopsis. J Cell Biol (1999) 3.14
Human lumbosacral spinal cord interprets loading during stepping. J Neurophysiol (1997) 3.09
Neural stem cells constitutively secrete neurotrophic factors and promote extensive host axonal growth after spinal cord injury. Exp Neurol (2003) 3.09
Noggin is a mesenchymally derived stimulator of hair-follicle induction. Nat Cell Biol (1999) 2.99
Diet-dependent shifts in the bacterial population of the rumen revealed with real-time PCR. Appl Environ Microbiol (2001) 2.98
Can preoperative urodynamic investigation be omitted in women with stress urinary incontinence? A non-inferiority randomized controlled trial. Neurourol Urodyn (2012) 2.98
Mutations in the Drosophila dTAK1 gene reveal a conserved function for MAPKKKs in the control of rel/NF-kappaB-dependent innate immune responses. Genes Dev (2001) 2.96
Functional participation of the IL-2 receptor gamma chain in IL-7 receptor complexes. Science (1994) 2.78
Cumulative sum technique and its application to the analysis of peristimulus time histograms. Electroencephalogr Clin Neurophysiol (1978) 2.75
Human lymphocytes making rheumatoid factor and antibody to ssDNA belong to Leu-1+ B-cell subset. Science (1987) 2.75
Impact of measurement and feedback on vaccination coverage in public clinics, 1988-1994. JAMA (1997) 2.74
The oligodendrocyte precursor cell in health and disease. Trends Neurosci (2001) 2.68
Dysmyelination in transgenic mice resulting from expression of class I histocompatibility molecules in oligodendrocytes. Nature (1991) 2.67
Electrosurgical bipolar vessel sealing versus conventional clamping and suturing for vaginal hysterectomy: a randomised controlled trial. BJOG (2012) 2.66
Spontaneous corticospinal axonal plasticity and functional recovery after adult central nervous system injury. Proc Natl Acad Sci U S A (2001) 2.65
International standards to document remaining autonomic function after spinal cord injury. Spinal Cord (2008) 2.65
Self-organization of microtubule asters induced in Xenopus egg extracts by GTP-bound Ran. Science (1999) 2.59
Who wants to walk? Preferences for recovery after SCI: a longitudinal and cross-sectional study. Spinal Cord (2008) 2.55
Mortality and medical comorbidity among psychiatric patients: a review. Psychiatr Serv (1996) 2.52
The interleukin-2 receptor gamma chain: its role in the multiple cytokine receptor complexes and T cell development in XSCID. Annu Rev Immunol (1996) 2.50
Mechanism of action of quinolones against Escherichia coli DNA gyrase. Antimicrob Agents Chemother (1993) 2.48
Nucleotide sequence of the asnA gene coding for asparagine synthetase of E. coli K-12. Nucleic Acids Res (1981) 2.42
Effect of Towne live virus vaccine on cytomegalovirus disease after renal transplant. A controlled trial. Ann Intern Med (1991) 2.42
Electrophysiological studies of gait in spasticity and rigidity. Evidence that altered mechanical properties of muscle contribute to hypertonia. Brain (1981) 2.40
Treadmill training of paraplegic patients using a robotic orthosis. J Rehabil Res Dev (2001) 2.37
The earliest electrocardiographic evidence of myocardial infarction. Br Heart J (1970) 2.37
The subependymal layer and neighboring region in the brain of the young rat. J Comp Neurol (1972) 2.29
Activity of single motor units from human forearm muscles during voluntary isometric contractions. J Neurophysiol (1975) 2.29
Cloning by functional expression of platelet-activating factor receptor from guinea-pig lung. Nature (1991) 2.28
Clinical subtypes of schizophrenia: differences in brain and CSF volume. Am J Psychiatry (1994) 2.27
Host range of human T-cell leukemia virus type I analyzed by a cell fusion-dependent reporter gene activation assay. Virology (1999) 2.21
Cloning, expression, and fatty acid regulation of the human delta-5 desaturase. J Biol Chem (1999) 2.19
Prevalence, pathogenesis, and treatment of renal dysfunction associated with chronic lithium therapy. Am J Kidney Dis (1987) 2.17
Genetic mutations in exons 3 and 4 of the pancreatic secretory trypsin inhibitor in patients with pancreatitis. J Gastroenterol (2001) 2.17
Proportion of DNA gyrase mutants among quinolone-resistant strains of Pseudomonas aeruginosa. Antimicrob Agents Chemother (1990) 2.17
Recombinant human Fas ligand induces alveolar epithelial cell apoptosis and lung injury in rabbits. Am J Physiol Lung Cell Mol Physiol (2001) 2.16
Functional assignment of the ORF2-iscS-iscU-iscA-hscB-hscA-fdx-ORF3 gene cluster involved in the assembly of Fe-S clusters in Escherichia coli. J Biochem (1999) 2.15
Long term effects of locomotor training in spinal humans. J Neurol Neurosurg Psychiatry (2001) 2.09
Cellular delivery of neurotrophin-3 promotes corticospinal axonal growth and partial functional recovery after spinal cord injury. J Neurosci (1997) 2.07
Selective expression of a novel surface molecule by human Th2 cells in vivo. J Immunol (1999) 2.07
Transplantation of in vitro-expanded fetal neural progenitor cells results in neurogenesis and functional recovery after spinal cord contusion injury in adult rats. J Neurosci Res (2002) 2.06
Interleukin 12-dependent interferon gamma production by CD8alpha+ lymphoid dendritic cells. J Exp Med (1999) 2.05
Dose comparison trial of sustained-release fampridine in multiple sclerosis. Neurology (2008) 2.04
Autologous collagen? Lipocytic dermal augmentation. A histopathologic study. J Dermatol Surg Oncol (1993) 2.04
Activation of endogenous c-fos proto-oncogene expression by human T-cell leukemia virus type I-encoded p40tax protein in the human T-cell line, Jurkat. J Virol (1989) 2.03
Anomalous origin of the left coronary artery from the pulmonary artery. New operative technique. J Thorac Cardiovasc Surg (1993) 2.02
Eosinophilic fasciitis. A pathologic study of twenty cases. Am J Pathol (1979) 2.02
Electrocardiogram of pure left ventricular hypertrophy and its differentiation from lateral ischaemia. Br Heart J (1981) 2.02
The Babinski sign: 100 years on. BMJ (1996) 2.01
EMA/CO for high-risk gestational trophoblastic tumors: results from a cohort of 272 patients. J Clin Oncol (1997) 2.00
Walking index for spinal cord injury (WISCI II): scale revision. Spinal Cord (2001) 2.00
Investigation of glial cells in semithin sections. I. Identification of glial cells in the brain of young rats. J Comp Neurol (1973) 1.99
Cellular distribution and developmental expression of AMP-activated protein kinase isoforms in mouse central nervous system. J Neurochem (1999) 1.99
Regeneration of CNS axons back to their target following treatment of adult rat brain with chondroitinase ABC. Nat Neurosci (2001) 1.99
De novo generation of neuronal cells from the adult mouse brain. Proc Natl Acad Sci U S A (1992) 1.97
Suppression of voluntary motor activity revealed using transcranial magnetic stimulation of the motor cortex in man. J Physiol (1994) 1.97
Noggin is required for induction of the hair follicle growth phase in postnatal skin. FASEB J (2001) 1.95
Neurocan is upregulated in injured brain and in cytokine-treated astrocytes. J Neurosci (2000) 1.95
Neutrophils exposed to bacterial lipopolysaccharide upregulate NADPH oxidase assembly. J Clin Invest (1998) 1.95
Enhanced HIV replication in macrophage colony-stimulating factor-treated monocytes. J Immunol (1991) 1.92